zur Navigation zum Inhalt
Onkologie 8. Oktober 2015

ASH 2014 update: Myelodysplastic syndromes and acute myeloid leukemia

Treatment of myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML), especially in older patients with comorbidities, is still a challenge and awaits further improvement regarding outcomes. Therefore data presented on this topic at the 2014 American Society of Hematology (ASH) meeting are of importance and need to be discussed in the context of current and future clinical practice. This review covers studies for AML and MDS (excluding transplantation) reported at the last ASH meeting that demonstrate progress in this field and suggest a way forward from chemotherapy to biological treatment approaches.

Zu diesem Thema wurden noch keine Kommentare abgegeben.

Mehr zum Thema

<< Seite 1 >>

Medizin heute

Aktuelle Printausgaben